ECJ should uphold Italian enforcer on Roche/Novartis, AG says

Advocate-General Henrik Øe has urged the European Court of Justice to rule in favour of a decision to fine Roche and Novartis for colluding to induce consumers to use a more expensive drug rather than a cheaper off-label alternative, and to confirm the Italian competition enforcer's finding of a by-object restriction of competition.

Unlock unlimited access to all Global Competition Review content